# Bio-marker Analysis Using Circulating Tumor Cells in Patients With Melanoma

> **NCT02828345** · — · WITHDRAWN · sponsor: **Abramson Cancer Center at Penn Medicine**

## Conditions studied

- Melanoma

## Interventions

- **OTHER:** Specimen Collection

## Key facts

- **NCT ID:** NCT02828345
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-11
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02828345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02828345, "Bio-marker Analysis Using Circulating Tumor Cells in Patients With Melanoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02828345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*